Delcath Systems Shares Spike, Co. Site Shows FDA Approval For HEPZATO Kit; EDIT: Website Has Since Been Taken Down
Portfolio Pulse from Benzinga Newsdesk
Delcath Systems' website shows that the FDA has approved its HEPZATO Kit, causing a spike in the company's shares.
August 04, 2023 | 5:18 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Delcath Systems' shares have spiked following the FDA approval of its HEPZATO Kit.
The FDA approval of Delcath Systems' HEPZATO Kit is a significant positive development for the company. This approval can lead to increased sales and revenues, which is likely to have a positive impact on the company's stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100